Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial

  • Read more about Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

  • Read more about SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

  • Read more about The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

  • Read more about Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

  • Read more about Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Relmada Therapeutics

By jpalfreyman on Thu, 09/07/2023 - 10:11
  • Read more about Relmada Therapeutics

Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

  • Read more about Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium

  • Read more about Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium

Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

  • Read more about Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

Effects of an Active Coping Program in Patients With Persistent Post-Covid Pain.

  • Read more about Effects of an Active Coping Program in Patients With Persistent Post-Covid Pain.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Current page 103
  • Page 104
  • Page 105
  • Page 106
  • Page 107
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA